Ignite Creation Date:
2024-05-06 @ 3:48 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04767373
Status:
COMPLETED
Last Update Posted:
2023-07-17
First Post:
2021-02-22
Brief Title:
Efficacy and Safety of Clesrovimab MK-1654 in Infants MK-1654-004
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-07
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-08-15
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-22
First Submit QC Date:
February 22 2021
Study First Post Date:
2021-02-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-15
Last Update Post Date:
2023-07-17
Last Update Post Date Type:
ACTUAL